Recombinant Human ZNF699 protein

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

ZNF699 also known as Zinc Finger Protein 699 is a protein encoded by the ZNF699 gene in humans. This protein consists of zinc finger motifs which are small protein structural motifs able to bind to DNA. The molecular mass of ZNF699 is approximately 90 kDa. It is expressed in various tissues with high levels observed in the brain liver and kidney. The primary function of ZNF699’s zinc finger domains involves binding to specific DNA sequences influencing transcriptional regulation of target genes.

Biological function summary

Zinc finger proteins like ZNF699 play important roles in gene expression. ZNF699 does not appear to be part of any large multiprotein complex but interacts with a variety of other molecules involved in transcriptional regulation. It acts by binding to regulatory regions of genes influencing the transcription process. This interaction directly affects cellular functions such as proliferation differentiation and response to external signals. The precise biological role of ZNF699 remains under continued investigation but existing studies suggest a regulatory function in various cellular processes.

Pathways

ZNF699 is involved in transcriptional regulatory pathways that govern gene expression. It participates particularly in the Wnt signaling pathway which plays a significant role in embryonic development and cell growth. ZNF699’s interaction with other transcription factors such as TCF/LEF highlights its contribution in modulating gene expression within this signaling pathway. Additionally ZNF699 may cross-talk with the Hedgehog signaling pathway via interactions that influence cell fate decisions and morphogenesis.

Researchers associate ZNF699 with certain cancers and developmental disorders. Its dysregulation may contribute to tumorigenesis influencing the expression of oncogenes and tumor suppressor genes. In some cancers ZNF699 may interact aberrantly with proteins like p53 which is a well-known tumor suppressor. Additionally alterations in ZNF699 expression may also be linked to congenital malformations potentially through disrupted regulatory networks involving proteins like GLI1 a Hedgehog pathway component. Continued research will help to define the precise role of ZNF699 in these conditions and its potential as a therapeutic target.